TargetMol

Glabridin

Product Code:
 
TAR-T3403
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T3403-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3403-20mg20mg£135.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3403-100mg100mg£224.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Glabridin may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels; may possess a therapeutic effect on metabolic disorders( such as diabetes and hyperglycemia), by modulating glucose metabolism through AMPK in skeletal muscle cells. Glabridin may have potential as a chemopreventive agent against liver Y metastasis, by inhibiting the invasion of human HCC cells.
CAS:
59870-68-7
Formula:
C20H20O4
Molecular Weight:
324.376
Pathway:
NF-κb; Proteases/Proteasome; DNA Damage/DNA Repair; Neuroscience; Metabolism; Membrane transporter/Ion channel; Microbiology/Virology; Immunology/Inflammation
Purity:
0.9984
SMILES:
CC1(C)Oc2ccc3C[C@@H](COc3c2C=C1)c1ccc(O)cc1O
Target:
Reactive Oxygen Species; Tyrosinase; GABA Receptor; Antibacterial; PPAR

References

El-Ashmawy NE, et al. Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology. 2018 Apr;26(2):551-559. Yokota Tm , et al. Pigment Cell Res. 1998 Dec;11(6):355-61. Hsieh MJ, et al. Br J Pharmacol. 2014 Jun;171(12):3037-50. Yehuda I, et al. Mol Nutr Food Res. 2015 Jun;59(6):1041-52.